XBiotech Purchases Automated Vial Filling Machine, Prompting Increased Manufacturing Capabilities
AUSTIN, Texas, Sept. 11, 2014 /PRNewswire/ -- XBiotech announced today it has taken delivery on its new high throughput filling machine that the Company says will be used to dramatically increase its fill finish capabilities. The fully integrated system is designed to fill, stopper and crimp vials, which is the final step in the manufacturing process. Additionally, the unit is said to contain an in-line feed back loop and a laser scanning system to provide a high level of quality compared to less sophisticated filling systems. The Company says the high-speed equipment will allow for an entire lot of drug product to be filled in hours, rather than batching and filling over days with the current process. The equipment will apparently allow for production of over 2,000,000 units of drug product annually, which the Company claims is enough to support launch of its commercial production operation.
Josh Combs, the Company's Vice President of Manufacturing, stated, "This system will allow us to manufacture our drug for a global market, and provide the highest level of quality attainable with a filling system, further solidifying our path to commercialization."
ABOUT XBIOTECH
XBiotech is a leading developer of biological therapiesincluding the discovery and development of True Human antibodies. The Company's lead product candidatein two Phase III clinical studiesis a novel, breakthrough treatment for advanced cancer. XBiotech has also developed manufacturing technology to reduce infrastructure needs, lessen capital requirements and reduce lead times for biological drugs.
Contact:
Ashley Otero
XBiotech
aotero@xbiotech.com
512.386.2930
SOURCE XBiotech